logo
Plus   Neg
Share
Email

Moderna Lifts FY21 Manufacturing Supply View; Plans To Supply Up To 3 Bln Doses In 2022

Moderna, Inc. (MRNA) announced Thursday that it is making new funding commitments to increase supply at its owned and partnered manufacturing facilities. With this, the company expects to increase global 2022 capacity to up to 3 billion doses of its COVID-19 vaccine.

The plans depend upon the mix between the authorized Moderna COVID-19 Vaccine at the 100 g dose level and potentially lower doses of the Company's variant booster candidates and pediatric vaccines, if authorized.

The company will use its cash balance to fund these investments.

Moderna also raised its 2021 manufacturing supply forecast to between 800 million to 1 billion doses.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Walt Disney World, the Orlando, Florida-based entertainment complex, is easing the health safety guidelines that were rolled out to prevent the spread of the ongoing COVID-19 pandemic. The complex is ending temperature checks in a phased manner following the advice of the Centers for Disease Control and Prevention (CDC) and local health officials. Frito-Lay North America, the convenient foods division of food and beverages giant PepsiCo, Inc., is recalling select Ruffles All Dressed Potato Chips citing the possible presence of undeclared milk ingredients, a known allergen, the U.S. Food and Drug Administration said. According to the agency, the recalled products may have distributed regionally to Walmart's Sam's Club Warehouses. Pfizer Inc. (PFE) and BioNTech SE (BNTX) announced Friday that they have initiated the Biologics License Application (BLA) process with the U.S. Food and Drug Administration (FDA) for approval of their mRNA vaccine to prevent COVID-19 in individuals 16 years of age and older. The companies initiated...
Follow RTT